DD291560A5 - Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten - Google Patents

Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten Download PDF

Info

Publication number
DD291560A5
DD291560A5 DD90337249A DD33724990A DD291560A5 DD 291560 A5 DD291560 A5 DD 291560A5 DD 90337249 A DD90337249 A DD 90337249A DD 33724990 A DD33724990 A DD 33724990A DD 291560 A5 DD291560 A5 DD 291560A5
Authority
DD
German Democratic Republic
Prior art keywords
nmr
calculated
formula
crystallized
tlc
Prior art date
Application number
DD90337249A
Other languages
German (de)
English (en)
Inventor
Kishor A Desai
Gene M Bright
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD291560A5 publication Critical patent/DD291560A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DD90337249A 1989-01-23 1990-01-22 Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten DD291560A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000275 WO1990008148A1 (fr) 1989-01-23 1989-01-23 Agents anxiolytiques bis-aza-bicycliques

Publications (1)

Publication Number Publication Date
DD291560A5 true DD291560A5 (de) 1991-07-04

Family

ID=22214801

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90337249A DD291560A5 (de) 1989-01-23 1990-01-22 Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten

Country Status (38)

Country Link
US (1) US5122525A (fr)
EP (1) EP0380217B1 (fr)
JP (1) JPH0643427B2 (fr)
KR (1) KR910009289B1 (fr)
CN (1) CN1022186C (fr)
AP (1) AP128A (fr)
AR (1) AR246969A1 (fr)
AT (1) ATE82574T1 (fr)
AU (1) AU614214B2 (fr)
BA (1) BA98302A (fr)
BG (1) BG51046A3 (fr)
CA (1) CA2008108C (fr)
CZ (1) CZ277698B6 (fr)
DD (1) DD291560A5 (fr)
DE (1) DE69000467T2 (fr)
DK (1) DK0380217T3 (fr)
EG (1) EG19306A (fr)
ES (1) ES2053094T3 (fr)
FI (1) FI95381C (fr)
GR (1) GR3006925T3 (fr)
HU (1) HU215154B (fr)
IE (1) IE62670B1 (fr)
IL (1) IL93073A (fr)
IS (1) IS1667B (fr)
MA (1) MA21735A1 (fr)
MX (1) MX19222A (fr)
MY (1) MY104861A (fr)
NO (1) NO175978C (fr)
NZ (1) NZ232168A (fr)
OA (1) OA10041A (fr)
PL (1) PL163836B1 (fr)
PT (1) PT92919B (fr)
RO (1) RO110142B1 (fr)
RU (1) RU2015977C1 (fr)
SK (1) SK279339B6 (fr)
WO (2) WO1990008148A1 (fr)
YU (1) YU47554B (fr)
ZA (1) ZA90430B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (fr) * 1989-01-23 1990-07-26 Pfizer Inc. Agents anxiolytiques bis-aza-bicycliques
WO1992000075A1 (fr) * 1990-06-29 1992-01-09 Pfizer Inc. Derives de pyridopyrazine utilises dans le traitement de l'abus et de la dependance de substances
ES2072141T3 (es) * 1991-01-31 1995-07-01 Pfizer Resolucion de trans-2-(2-pirimidinil)-7-(hidroximetil)octahidro-2h-pirido(1,2a)pirazina.
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
CA2195622C (fr) * 1991-02-27 1999-08-17 Frank J. Urban Methode de preparation de trans-piperidine-2,5-dicarboxylates
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
US5311195A (en) * 1991-08-30 1994-05-10 Etak, Inc. Combined relative and absolute positioning method and apparatus
EP0607163B1 (fr) * 1991-09-25 1996-12-11 Pfizer Inc. 2-SUBSTITUEES PERHYDRO-1-H-PYRIDO[1,2-a]PYRAZINES UTILISES COMME NEUROLEPTIQUES
JP2753146B2 (ja) * 1992-06-16 1998-05-18 ファイザー・インコーポレーテッド ビス−アザー二環式抗不安薬の製法および中間体
WO1994006794A1 (fr) * 1992-09-24 1994-03-31 National Institutes Of Health Derives d'aralkyle diazabicycloalcane contre des troubles du systeme nerveux central
IL104506A (en) * 1993-01-25 1997-11-20 Israel State Fast changing heating- cooling device and method, particularly for cryogenic and/or surgical use
US5637713A (en) * 1993-08-20 1997-06-10 Pfizer Inc. Process for preparing trans-piperidine-2,5-dicarboxylates
US5455350A (en) * 1993-10-13 1995-10-03 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
IL107460A (en) * 1993-11-01 1999-06-20 Israel State Controlled cryogenic contact system
WO1996010570A1 (fr) * 1994-09-30 1996-04-11 Pfizer Inc. PERHYDRO-1H-PYRIDO[1,2-a] PYRAZINES DISUBSTITUEES EN 2,7 A ACTION NEUROLEPTIQUE
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
AU681310B2 (en) * 1994-09-30 1997-08-21 Pfizer Inc. 2,7-substituted octahydro-1h-pyrido{1,2-a}pyrazine derivatives
JP3204456B2 (ja) * 1995-12-21 2001-09-04 ファイザー・インコーポレーテッド ２，７―置換オクタヒドロ―ピロロ［１，２―ａ］ピラジン誘導体
IL127037A0 (en) * 1996-07-01 1999-09-22 Pfizer Preparation of (7s trans)-2- (2-pyrimidinyl)-7- (hydroxamethyl) octahydro-2h- pyrido [1,2-a] pyrazine
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
AP2005003390A0 (en) * 2003-03-12 2005-09-30 Pfizer Prod Inc Pyridyloxymethyl and benzisoxazole azabicyclic derivatives.
EP1633756B1 (fr) 2003-04-09 2008-12-24 Biogen Idec MA Inc. Antagonistes de recepteur d'adenosine a2a
US7671072B2 (en) * 2003-11-26 2010-03-02 Pfizer Inc. Aminopyrazole derivatives as GSK-3 inhibitors
WO2005115396A2 (fr) * 2004-05-27 2005-12-08 Warner-Lambert Company Llc Combinaison therapeutique pour troubles d'hyperactivite avec deficit de l'attention
US7658206B2 (en) 2006-12-05 2010-02-09 Kohler Co. Plumbing valve with stick control handle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4339579A (en) * 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US4414389A (en) * 1982-05-25 1983-11-08 American Home Products Corporation 4-Substituted-piperidino carboxamides
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3409440A1 (de) * 1984-03-15 1985-09-26 Bayer Ag, 5090 Leverkusen Imidazo(1,5-a)pyridyl-methan- und imidazo(1,5-b)pyridazinylmethan-derivate, ihre herstellung und sie enthaltende aufzeichnungsmaterialien
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
JP2668259B2 (ja) * 1988-02-18 1997-10-27 塩野義製薬株式会社 複素環化合物および抗潰瘍剤
WO1990008148A1 (fr) * 1989-01-23 1990-07-26 Pfizer Inc. Agents anxiolytiques bis-aza-bicycliques

Also Published As

Publication number Publication date
JPH0643427B2 (ja) 1994-06-08
WO1990008148A1 (fr) 1990-07-26
NO912863L (no) 1991-07-22
PT92919B (pt) 1995-12-29
NO912863D0 (no) 1991-07-22
KR900011774A (ko) 1990-08-02
KR910009289B1 (ko) 1991-11-09
IE900225L (en) 1990-07-23
IS3529A7 (is) 1990-07-24
RO110142B1 (ro) 1995-10-30
WO1990008144A1 (fr) 1990-07-26
MY104861A (en) 1994-06-30
ZA90430B (en) 1991-08-28
HU215154B (hu) 2000-09-28
AP128A (en) 1991-03-20
GR3006925T3 (fr) 1993-06-30
IE62670B1 (en) 1995-03-08
MA21735A1 (fr) 1990-10-01
PT92919A (pt) 1990-07-31
BA98302A (bs) 2001-09-14
NO175978C (no) 1995-01-11
AU614214B2 (en) 1991-08-22
YU47554B (sh) 1995-10-03
ES2053094T3 (es) 1994-07-16
EP0380217A1 (fr) 1990-08-01
IS1667B (is) 1997-11-14
BG51046A3 (en) 1993-01-15
AP9000158A0 (en) 1990-01-31
RU2015977C1 (ru) 1994-07-15
CN1044464A (zh) 1990-08-08
MX19222A (es) 1993-12-01
PL163836B1 (pl) 1994-05-31
YU11190A (sh) 1993-05-28
CA2008108C (fr) 1995-08-08
CZ277698B6 (en) 1993-03-17
CS29990A3 (en) 1992-11-18
DK0380217T3 (da) 1992-12-14
OA10041A (en) 1996-10-14
EG19306A (en) 1995-01-31
DE69000467T2 (de) 1993-04-01
AU4867990A (en) 1990-07-26
AR246969A1 (es) 1994-10-31
HUT63163A (en) 1993-07-28
NZ232168A (en) 1991-08-27
FI95381B (fi) 1995-10-13
SK279339B6 (sk) 1998-10-07
FI95381C (fi) 1996-01-25
JPH02233681A (ja) 1990-09-17
NO175978B (no) 1994-10-03
IL93073A (en) 1994-05-30
CA2008108A1 (fr) 1990-07-23
US5122525A (en) 1992-06-16
DE69000467D1 (de) 1992-12-24
ATE82574T1 (de) 1992-12-15
CN1022186C (zh) 1993-09-22
EP0380217B1 (fr) 1992-11-19
FI913510A0 (fi) 1991-07-22

Similar Documents

Publication Publication Date Title
DD291560A5 (de) Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2915318A1 (de) Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE60026883T2 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69824195T2 (de) Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems
DE2647041C2 (de) 3-Aminomethylen-6,7-dimethoxy-2- methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester
DE69726749T2 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
DE2460929C2 (fr)
EP0061056A1 (fr) 5,6-Diméthylpyrrolo (2,3-b) pyridines, procédé pour leur préparation et leur utilisation comme médicament
EP0180115A2 (fr) 1,2,4-Triazolyl carbamates et leurs sels d'addition acides, procédé pour leur préparation et médicaments
DE2229845B2 (de) 6-o-Halogenphenyl-4H-s-triazolo [3,4-c] thieno [2,3e] [1,4] diazepine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Massen
DE4131584A1 (de) Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
DE3643666A1 (de) Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0172526B1 (fr) Benzodiazépines, procédé pour leur préparation et leur application
EP0003286B1 (fr) Dérivés d'alcaloides ergopeptidiques, procédé pour leur préparation et compositions pharmaceutiques les contenant
DE3709699C2 (de) 5-Fluoruracil-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69907448T2 (de) Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden
DD263531A5 (de) Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
DD294944A5 (de) Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen
DE2627190A1 (de) Neue fuenfring-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
EP0167045A1 (fr) Benzo[c][1,8]naphtyridines, procédé pour leur préparation, leur utilisation et compositions contenant ces composés
DE2634910A1 (de) Quartaere kondensierte heterocyclische salze sowie antidiabetika
DE3843481A1 (de) Substituierte 3-azabicyclo/3.1.1/heptane, ihre herstellung und ihre verwendung
DE2550163A1 (de) Neue derivate des eckige klammer auf 1,4 eckige klammer zu oxathiino eckige klammer auf 2,3-c eckige klammer zu pyrrols, deren herstellung und diese enthaltende zusammensetzungen
DD300406A5 (de) Verwendung von 10-Amino-5,6-Dihydro 11h-Dibenzo (B,e) Azepin-6,11-dion und Derivaten als Arzneimittel zur Behandlung von Inkontinenz

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee